Y-Intercept (HK)’s Idexx Laboratories IDXX Stock Holding History

Y-Intercept (HK)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.33M	Sell	4,469 -11,861	-73%	-$6.5M	0.05%	552
2026 Q2	$8.6M	Buy	16,330 +2,665	+20%	+$1.49M	0.17%	124
2026 Q1	$7.68M	Buy	13,665 +8,181	+149%	+$5.25M	0.15%	179
2025 Q4	$3.71M	Buy	5,484 +4,437	+424%	+$3.02M	0.08%	330
2025 Q3	$669K	Buy	+1,047	New	+$636K	0.02%	1156
2025 Q2	–	Sell	-1,609	Closed	-$676K	–	1796
2025 Q1	$676K	Sell	1,609 -7,523	-82%	-$3.27M	0.05%	568
2024 Q4	$3.78M	Buy	9,132 +6,633	+265%	+$2.91M	0.25%	90
2024 Q3	$1.26M	Buy	+2,499	New	+$1.21M	0.08%	349
2024 Q2	–	Sell	-2,548	Closed	-$1.38M	–	1617
2024 Q1	$1.38M	Buy	+2,548	New	+$1.39M	0.1%	268
2023 Q4	–	Sell	-6,176	Closed	-$2.7M	–	1414
2023 Q3	$2.7M	Buy	+6,176	New	+$3.08M	0.26%	86
2023 Q1	–	Sell	-6,642	Closed	-$2.71M	–	1334
2022 Q4	$2.71M	Buy	6,642 +5,171	+352%	+$2.01M	0.4%	25
2022 Q3	$479K	Sell	1,471 -3,585	-71%	-$1.32M	0.05%	555
2022 Q2	$1.77M	Buy	+5,056	New	+$2.06M	0.23%	108
2021 Q4	–	Sell	-2,892	Closed	-$1.8M	–	707
2021 Q3	$1.8M	Buy	+2,892	New	+$1.94M	0.33%	80
2021 Q2	–	Sell	-742	Closed	-$353K	–	744
2021 Q1	$353K	Buy	+742	New	+$372K	0.09%	344

Other funds holding IDXX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AustralianSuper Melbourne, Australia $24.4B AUM 44.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Y-Intercept (HK)'s IDXX Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Idexx Laboratories (IDXX) stake by 73% in Q3 2026, selling an estimated $6.5M and leaving 4,469 shares worth $2.33M. The position accounts for 0.05% of the portfolio, ranked #552.

Y-Intercept (HK) first reported a position in IDXX in Q1 2021 and has held it in 15 quarters since. The position peaked at $8.6M in Q2 2026. 804 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Y-Intercept (HK) held 4,469 shares of Idexx Laboratories worth $2.33M as of Q3 2026.
Y-Intercept (HK) sold 11,861 Idexx Laboratories shares in Q3 2026, an estimated $6.5M.
Idexx Laboratories made up 0.05% of Y-Intercept (HK)'s portfolio in Q3 2026, its #552 holding.
Y-Intercept (HK) first reported a position in Idexx Laboratories in Q1 2021 and has held it in 15 quarters since.
Y-Intercept (HK)'s Idexx Laboratories position peaked at $8.6M in Q2 2026.
804 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.